Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis

OBJECTIVES: To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage. METHODS: Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial spondyloarthritis in the Swiss Clinical Qua...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Hebeisen, Monika, Scherer, Almut, Micheroli, Raphael, Nissen, Michael J., Tamborrini, Giorgio, Möller, Burkhard, Zufferey, Pascal, Exer, Pascale, Ciurea, Adrian
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6542531/
https://ncbi.nlm.nih.gov/pubmed/31145730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0216746
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados